In contrast to the ongoing controversy regarding the nature of changes in WFA/CS-GAG+ and aggrecan/CSPG+ PNN subtypes in postmortem AD brain tissue, a more broadly accepted pattern describing the spatial distribution of AD neuropathology and PNN matrices has emerged. Here, ACAN is linked to Alzheimer disease.